Atossa Therapeutics Appoints Breast Cancer Specialist Tessa

SEATTLE, March 12, 2024 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a...

Related Keywords

New York , United States , Tessa Cigler , Eric Van Zanten , Weill Cornell , Globenewswire Inc , Harvard College , Weill Cornell Breast Center , Duke University School Of Medicine , York Presbyterian Hospital Weill Cornell Medical Center , Dana Farber Harvard Cancer Center , Master In Public Health , Atossa Therapeutics Inc , Exchange Commission , Harvard School Of Public Health , Nasdaq , Chief Executive , University School , Public Health , Internal Medicine , Medical Oncology , Weill Cornell Breast , Selective Estrogen Receptor Modulator , Private Securities Litigation Reform Act , Stock Market , Annual Reports , Quarterly Reports ,